We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTG icon
9801
PUT
Heritage Insurance Holdings
HRTG
$913M
$152K ﹤0.01%
+15,000
New +$154K
ARDX icon
9802
CALL
Ardelyx
ARDX
$1.21B
$151K ﹤0.01%
+23,300
New +$138K
KRMD icon
9803
PUT
KORU Medical Systems
KRMD
$188M
$151K ﹤0.01%
25,100
+13,800
+122% +$77.2K
NRDY icon
9804
Nerdy
NRDY
$105M
$151K ﹤0.01%
+13,580
New +$148K
ROCC
9805
PUT
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$151K ﹤0.01%
14,900
-179,700
-92% -$1.7M
MACK
9806
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$151K ﹤0.01%
+21,943
New +$108K
AXDX
9807
CALL
DELISTED
Accelerate Diagnostics
AXDX
$150K ﹤0.01%
1,980
-1,370
-41% -$123K
SLAI
9808
CALL
DELISTED
SOLAI Ltd ADS
SLAI
$150K ﹤0.01%
+239
New +$53.3K
HLX icon
9809
CALL
Helix Energy Solutions
HLX
$1.38B
$150K ﹤0.01%
35,600
-2,900
-8% -$9.69K
SCM icon
9810
Stellus Capital Investment Corp
SCM
$230M
$150K ﹤0.01%
13,840
-14,705
-52% -$146K
VET icon
9811
CALL
Vermilion Energy
VET
$1.64B
$150K ﹤0.01%
33,700
+17,500
+108% +$62.2K
ENLC
9812
PUT
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$150K ﹤0.01%
40,300
-4,800
-11% -$15.7K
NBLX
9813
CALL
DELISTED
Noble Midstream Partners LP
NBLX
$150K ﹤0.01%
14,400
-16,900
-54% -$157K
CWK icon
9814
Cushman & Wakefield Ltd
CWK
$3.28B
$149K ﹤0.01%
+10,024
New +$139K
IRWD icon
9815
CALL
Ironwood Pharmaceuticals
IRWD
$701M
$149K ﹤0.01%
+13,100
New +$143K
SNDL icon
9816
CALL
Sundial Growers
SNDL
$312M
$149K ﹤0.01%
31,470
+17,120
+119% +$58.9K
AMPE
9817
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$149K ﹤0.01%
312
+151
+94% +$49.5K
ENBL
9818
CALL
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$149K ﹤0.01%
28,400
-24,400
-46% -$124K
TGNA
9819
CALL
DELISTED
TEGNA Inc
TGNA
$148K ﹤0.01%
10,600
-4,900
-32% -$65.5K
UMH
9820
CALL
UMH Properties
UMH
$1.29B
$148K ﹤0.01%
10,000
-2,000
-17% -$29.1K
SCPE.WS
9821
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
$148K ﹤0.01%
109,287
+169
+0.2% +$209
CMO
9822
CALL
DELISTED
Capstead Mortgage Corp.
CMO
$148K ﹤0.01%
+25,400
New +$145K
ADMA icon
9823
CALL
ADMA Biologics
ADMA
$2.13B
$147K ﹤0.01%
75,500
+3,700
+5% +$7.78K
OBDC icon
9824
CALL
Blue Owl Capital
OBDC
$5.43B
$147K ﹤0.01%
+11,600
New +$147K
EMAN
9825
DELISTED
eMagin Corporation
EMAN
$147K ﹤0.01%
89,186
+77,584
+669% +$99.7K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.